Diagnostic Photonics, a Serra Capital I and II portfolio company, was featured in the Chicago Tribune on January 7. The Chicago startup has successfully raised $3.1M to fund a clinical trial for its high-resolution imaging probes for cancer surgeons.

The new funding will contribute to a nationwide, 400-person study with the goal of gaining FDA clearance. Serra Ventures was listed in the article as an investor in the round.

Olio Devices, a Serra Capital II portfolio company, was recently listed among 42 “disruptive wearables” companies by CB Insights. Olio Devices creates luxury lifestyle products for the modern professional by collaborating with brand name fashion designers.

The next step in computing beyond smartphones and tablets could be wearables. Startups in the space are taking aim at large industries like apparel and healthcare. The selected 42 companies raised a combined $1.9B in investment over 105 deals. More than one quarter of the chosen startups were early stage companies. Serra Ventures was one among two listed as investors of Olio.